# Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms

> **NCT07356765** · NA · ENROLLING_BY_INVITATION · sponsor: **Tianjin Anding Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Schizophrenia
- Negative Symptoms of Schizophrenia

## Interventions

- **DRUG:** Berberine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07356765
- **Lead sponsor:** Tianjin Anding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-09-26
- **Primary completion:** 2026-01
- **Final completion:** 2026-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-27

## Collaborators

- Shanghai Mental Health Center

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07356765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07356765, "Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07356765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*